Dr. Marathi has served as Senior Vice President of the company since 2007, and has been involved with all areas of formulation development, manufacturing and clinical trials since 2004. Dr. Marathi is co-inventor of technology utilized by the company, and has led the development of PL2200 Aspirin from inception through FDA approval.
He has recently founded an immuno-oncology company, 7 Hills Pharma LLC. He was previously with BCM Technologies, the venture subsidiary and incubator for the Baylor College of Medicine where he was involved in the founding and launch of several biotechnology companies, including drug discovery, bio-tool and pharmaceutical companies. Prior to BCMT, Dr. Marathi was a post-doctoral fellow at St. Jude Children’s Research Hospital and the University of Texas M.D. Anderson Cancer Center, and earned a Ph.D. in Pharmacology and Experimental Therapeutics from Loyola University. He has more than 20 years of drug development experience in increasing the safety and efficacy of approved cancer and pain products. Dr. Marathi has served on the Faculty of the Jones School of Management at Rice University.